Tag: plasma fractionation industry.

Unlock Global Insights – Save 20% on Market Reports with Code ONLINE20

What Is The Future Market Size Estimation For The Plasma Fractionation Market Covering 2025–2034?

The plasma fractionation market has experienced significant expansion in recent years. Forecasts indicate it will surge from $31.42 billion in 2024 to $34.14 billion in 2025, demonstrating a compound annual growth rate (CAGR) of 8.6%. This historical development is primarily due to the rising prevalence of hemophilia and immunodeficiency disorders, an expanding aging demographic, an increasing need for immunoglobulins, the spread of plasma collection centers, and an uptick in surgical procedures.

The plasma fractionation market size is anticipated to experience substantial expansion in the coming years. By 2029, it is projected to attain a valuation of $50.54 billion, demonstrating a compound annual growth rate (CAGR) of 10.3%. This growth over the forecast period stems from factors such as increasing global healthcare expenditure, broader applications of plasma-derived medicinal products, heightened investment in research and development, a rising need for plasma in treating neurological disorders, and the expansion of plasma fractionation facilities. Significant developments expected during this timeframe encompass the creation of novel fractionation technologies, a pivot towards albumin and immunoglobulin therapies, an escalating demand for specialty plasma products, a dedicated focus on pathogen inactivation technologies, and strategic alliances and partnerships within the plasma industry.

Unlock Your Free Sample Report for Exclusive Market Data:

https://www.thebusinessresearchcompany.com/sample.aspx?id=7543&type=smp

What Are The Emerging Market Drivers Creating New Opportunities In The Plasma Fractionation Industry?

The growing prevalence of chronic diseases is anticipated to drive the expansion of the plasma fractionation market. These are conditions persisting for a year or longer, necessitating continuous medical care, with examples encompassing heart disease, cancer, and diabetes. Utilizing plasma products for treating individuals with chronic ailments lessens illness severity, enhances life quality, and proves economical, consequently boosting the demand for plasma fractionation. As an illustration, a report released in January 2023 by the National Library of Medicine, a US-based agency, indicates that the population aged 50 and above in the United States suffering from one or more chronic conditions is forecast to increase by 99.5%, escalating from 71.522 million in 2020 to 142.66 million by 2050. Thus, the rising incidence of chronic diseases is fueling the growth of the healthcare analytical testing service market. Consequently, an expanding number of chronic diseases across all age groups is poised to advance the plasma fractionation market growth.

What Are The Major Segments Identified In The Plasma Fractionation Market?

The plasma fractionation market covered in this report is segmented –

1) By Product: Immunoglobulins, Coagulation Factors, Albumin, Protease Inhibitors

2) By Application: Immunology, Hematology, Neurology, Critical Care, Hemato-Oncology, Rheumatology

3) By End User: Hospitals and Clinics, Clinical Research Laboratories, Academic Institutes

Subsegments:

1) By Immunoglobulins: Intravenous Immunoglobulin (IVIG), Subcutaneous Immunoglobulin (SCIG)

2) By Coagulation Factors: Factor VIII, Factor IX, Prothrombin Complex Concentrates (PCC)

3) By Albumin: Human Albumin, Bovine Serum Albumin (BSA)

4) By Protease Inhibitors: Alpha-1 Antitrypsin (AAT), C1 Esterase Inhibitor (C1-INH)

What Trends Are Redefining The Plasma Fractionation Market Dynamics?

Major companies within the market are implementing new technologies, such as advanced facility processes that transform donated human plasma into essential medicines, making the procedure more efficient and secure. For instance, in March 2023, the German-based company CSL Behring inaugurated a new $470 million plasma fractionation facility. This facility incorporates cutting-edge technology to enhance the efficiency and safety of plasma processing, thereby ensuring higher quality and more reliable medicines. By expanding the supply of these critical medicines, the facility helps to satisfy the increasing demand, ensuring a greater number of patients have access to life-saving treatments. Additionally, its advanced automation and self-cleaning systems reduce the potential for contamination and improve overall hygienic conditions, further enhancing patient safety.

Which Leading Companies Dominate The Plasma Fractionation Market Share?

Major companies operating in the plasma fractionation market include Baxter International Inc., Bio Products Laboratory Limited, Biotest AG, CSL Limited, Grifols S. A, ADMA Biologics Inc., Green Cross Corporation, Hualan Bioengineering Inc., Intas Pharmaceuticals Ltd., Japan Blood Products Organization, Kedrion S. P. A., Kamada Ltd., LFB Biomedicaments S. A. S, Octapharma AG, Sanquin Plasma Products B. V., Shanghai Raas Blood Products Co. Ltd., Takeda Pharmaceutical Company, Terumo BCT, China Biologic Products Holdings Inc., China National Biotec Group, Emergent BioSolutions Inc., Bharat Serum Vaccines Limited, Plasma Therapeutics, Prothya Biosolutions B. V., BioPharma Plasma LLC, BioLife Plasma Services LP

Download The Full Report For Exclusive Market Findings:

https://www.thebusinessresearchcompany.com/report/plasma-fractionation-global-market-report

What Regional Growth Trends Are Shaping The Plasma Fractionation Market Outlook?

North America was the largest region in the plasma fractionation market in 2024.Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the plasma fractionation market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Request A Customized Version Of The Plasma Fractionation Market Report:

https://www.thebusinessresearchcompany.com/customise?id=7543&type=smp

Browse Through More Reports Similar to the Global Plasma Fractionation Market 2025, By The Business Research Company

Blood And Blood Components Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/blood-and-blood-components-global-market-report

Convalescent Plasma Therapy Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/convalescent-plasma-therapy-global-market-report

Patient Blood Management Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/patient-blood-management-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Claim 20% Off Global Market Reports With Code ONLINE20 – Insights on Tariff Effects, Global Trade, and Industry Disruptors

What Is The Predicted Market Size Of The Plasma Fractionation Industry By 2029?

Over the past few years, the plasma fractionation market has seen substantial growth. The market value is expected to rise from $31.42 billion in 2024 to $34.14 billion in 2025, with a compound annual growth rate (CAGR) of 8.6%. Factors contributing to this growth during the historic period include an increasing occurrence of hemophilia and immunodeficiency disorders, an aging population, a surge in demand for immunoglobulins, and the development of more plasma collection centers. Additionally, the number of surgical procedures have also been on the rise.

In the coming years, a swift expansion is anticipated for the plasma fractionation market, reaching a projected value of $50.54 billion in 2029, with a 10.3% compound annual growth rate (CAGR). This growth in the forecast range is predicated on a surge in global health care spending, heightened use of plasma-based medicinal products, an increase in R&D investment, the need for plasma in handling neurological conditions, and the enlargement of plasma fractionation facilities. Key trends for the forecast period include the emergence of novel fractionation technologies, a move towards albumin and immunoglobulin treatments, growing demand for specific plasma products, emphasis on pathogen inactivation methodologies, as well as strategic alliances and collaborations within the plasma sector.

Get A Free Sample Of The Report:

https://www.thebusinessresearchcompany.com/sample.aspx?id=7543&type=smp

Which Growth Drivers Are Shaping The Plasma Fractionation Market Outlook?

The plasma fractionation market is predicted to experience expansive growth due to the rising prevalence of chronic illnesses. Chronic illnesses are typically defined as conditions that persist for at least one year and necessitate continuous medical intervention. Some prevalent examples of these diseases include heart disease, cancer, and diabetes. The administration of plasma products to patients suffering from these chronic conditions not only diminishes morbidity but also enhances their quality of life in a cost-effective manner. This leads to an increased demand for plasma fractionation. To illustrate, a report released by the US-based National Library of Medicine in January 2023 projected that the number of individuals aged 50 and above living with one or more chronic diseases would rise by 99.5% to reach 142.66 million by 2050, a significant increase from 71.522 million in 2020 in the United States. As such, the escalating incidence of chronic diseases is spurring on the growth of the healthcare analytical testing service market. Hence, the anticipated surge in chronic diseases across all age groups is expected to encourage the growth of the plasma fractionation market.

How Is The Global Plasma Fractionation Market Broken Down By Segment?

The plasma fractionation market covered in this report is segmented –

1) By Product: Immunoglobulins, Coagulation Factors, Albumin, Protease Inhibitors

2) By Application: Immunology, Hematology, Neurology, Critical Care, Hemato-Oncology, Rheumatology

3) By End User: Hospitals and Clinics, Clinical Research Laboratories, Academic Institutes

Subsegments:

1) By Immunoglobulins: Intravenous Immunoglobulin (IVIG), Subcutaneous Immunoglobulin (SCIG)

2) By Coagulation Factors: Factor VIII, Factor IX, Prothrombin Complex Concentrates (PCC)

3) By Albumin: Human Albumin, Bovine Serum Albumin (BSA)

4) By Protease Inhibitors: Alpha-1 Antitrypsin (AAT), C1 Esterase Inhibitor (C1-INH)

Which Trends Are Likely To Redefine Growth Paths In The Plasma Fractionation Market?

Main players in the market are coming up with innovative technologies, including state-of-the-art facility treatments that transform donated human plasma into vital medications. They also utilize cutting-edge technology for more secure and efficient processing. For instance, CSL Behring, based in Germany, inaugurated a $470 million plasma fractionation facility in March 2023, which harnesses ground-breaking technology to enhance plasma processing’s safety and efficiency, thereby ensuring the production of higher quality and more reliable medications. The facility contributes to the increased availability of these crucial drugs, thereby satisfying the escalating demand and assuring that more individuals can avail of the life-saving remedies. Thanks to sophisticated automation and self-sanitizing systems, the risk of contamination is decreased and hygienic conditions are improved, thereby augmenting patient safety.

Who Are The Primary Market Leaders In The Plasma Fractionation Market?

Major companies operating in the plasma fractionation market include Baxter International Inc., Bio Products Laboratory Limited, Biotest AG, CSL Limited, Grifols S. A, ADMA Biologics Inc., Green Cross Corporation, Hualan Bioengineering Inc., Intas Pharmaceuticals Ltd., Japan Blood Products Organization, Kedrion S. P. A., Kamada Ltd., LFB Biomedicaments S. A. S, Octapharma AG, Sanquin Plasma Products B. V., Shanghai Raas Blood Products Co. Ltd., Takeda Pharmaceutical Company, Terumo BCT, China Biologic Products Holdings Inc., China National Biotec Group, Emergent BioSolutions Inc., Bharat Serum Vaccines Limited, Plasma Therapeutics, Prothya Biosolutions B. V., BioPharma Plasma LLC, BioLife Plasma Services LP

Access The Complete Report Here:

https://www.thebusinessresearchcompany.com/report/plasma-fractionation-global-market-report

Which Regional Markets Are Emerging As Key Hubs For The Plasma Fractionation Market?

North America was the largest region in the plasma fractionation market in 2024.Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the plasma fractionation market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Customize Your Report Here:

https://www.thebusinessresearchcompany.com/customise?id=7543&type=smp

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

How Will the Plasma Fractionation Market Evolve in Terms of Growth and Size by 2029?

In recent times, the plasma fractionation market has experienced significant growth. The market size is projected to escalate from $31.42 billion in 2024 to $34.14 billion in 2025, presenting a compound annual growth rate (CAGR) of 8.6%. The historical growth can be attributed to increasing occurrences of hemophilia and immunodeficiency disorders, an aging population, heightened demand for immunoglobulins, expansion of plasma collection centers, and a surge in surgical procedures.

In the coming years, the market size for plasma fractionation is predicted to experience swift expansion, with an expected worth projecting as high as $50.54 billion in 2029, demonstrating a compound annual growth rate (CAGR) of 10.3%. This anticipated growth over the forecast period can be tied to factors such as increased global healthcare spending, a surge in the usage of plasma-derived medications, greater investments in R&D, a heightened demand for plasma in addressing neurological conditions, and a wider dispersal of plasma fractionation facilities. The forecast period is also set to witness key trends, including the emergence of fresh fractionation technologies, a leaning towards albumin and immunoglobulin therapies, increased demand for specialty plasma products, a spotlight on pathogen inactivation technologies, along with strategic alliances and partnerships within the plasma industry.

Download The Free Sample Report Here:

https://www.thebusinessresearchcompany.com/sample.aspx?id=7543&type=smp

What factors are expected to fuel Plasma Fractionation market growth in the coming years?

The plasma fractionation market is anticipated to expand due to the rising prevalence of chronic diseases. These diseases, which include heart disease, cancer, and diabetes, are illnesses that persist for a duration of one year or more, necessitating sustained medical care. The utilization of plasma products to treat patients suffering from chronic ailments not only mitigates morbidity and enhances their quality of life but also offers cost-efficiency which in turn fuels plasma fractionation demand. For example, the National Library of Medicine, a US authority, released a report in January 2023 suggesting that the count of individuals over 50 having one or more chronic diseases is anticipated to surge by 99.5%, reaching 142.66 million by 2050 from 71.522 million in 2020. Consequently, the rising occurrence of chronic diseases is stimulating the healthcare analytical testing service market’s growth. Thus, the escalation in chronic diseases across all age groups is projected to drive the expansion of the plasma fractionation market.

What Are The Key Findings From The Segmentation Analysis Of The Plasma Fractionation Market?

The plasma fractionation market covered in this report is segmented –

1) By Product: Immunoglobulins, Coagulation Factors, Albumin, Protease Inhibitors

2) By Application: Immunology, Hematology, Neurology, Critical Care, Hemato-Oncology, Rheumatology

3) By End User: Hospitals and Clinics, Clinical Research Laboratories, Academic Institutes

Subsegments:

1) By Immunoglobulins: Intravenous Immunoglobulin (IVIG), Subcutaneous Immunoglobulin (SCIG)

2) By Coagulation Factors: Factor VIII, Factor IX, Prothrombin Complex Concentrates (PCC)

3) By Albumin: Human Albumin, Bovine Serum Albumin (BSA)

4) By Protease Inhibitors: Alpha-1 Antitrypsin (AAT), C1 Esterase Inhibitor (C1-INH)

Which Emerging Trends And Strategic Shifts Are Shaping The Plasma Fractionation Market?

Leading players in the market are adopting innovative technologies, for example, advanced facility processes that convert donated human plasma into crucial drugs, utilizing progressive technology to ensure the procedure is more safe and efficient. To exemplify, in March 2023, CSL Behring, a Germany-based company, inaugurated a new plasma fractionation facility with an investment of $470 million which employs state-of-the-art technology towards enhancing the efficiency and safety of plasma processing. This optimizes the quality and reliability of medical products. The increased supply of these essential drugs enabled by this facility caters to the escalating demand, guaranteeing broader patient access to vital treatment options. The facility also lowers contamination risks and improves hygiene standards due to its advanced automation and self-cleaning systems, thereby increasing patient safety.

What Are The Most Active Companies In The Plasma Fractionation Market Today?

Major companies operating in the plasma fractionation market include Baxter International Inc., Bio Products Laboratory Limited, Biotest AG, CSL Limited, Grifols S. A, ADMA Biologics Inc., Green Cross Corporation, Hualan Bioengineering Inc., Intas Pharmaceuticals Ltd., Japan Blood Products Organization, Kedrion S. P. A., Kamada Ltd., LFB Biomedicaments S. A. S, Octapharma AG, Sanquin Plasma Products B. V., Shanghai Raas Blood Products Co. Ltd., Takeda Pharmaceutical Company, Terumo BCT, China Biologic Products Holdings Inc., China National Biotec Group, Emergent BioSolutions Inc., Bharat Serum Vaccines Limited, Plasma Therapeutics, Prothya Biosolutions B. V., BioPharma Plasma LLC, BioLife Plasma Services LP

Get The Full Report Here:

https://www.thebusinessresearchcompany.com/report/plasma-fractionation-global-market-report

Which Regional Markets Are Attracting The Most Investment In Plasma Fractionation?

North America was the largest region in the plasma fractionation market in 2024.Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the plasma fractionation market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Request For A Customized Report:

https://www.thebusinessresearchcompany.com/customise?id=7543&type=smp

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

How Will the Plasma Fractionation Market Evolve in Terms of Growth and Size by 2029?

In recent times, the plasma fractionation market has experienced significant growth. The market size is projected to escalate from $31.42 billion in 2024 to $34.14 billion in 2025, presenting a compound annual growth rate (CAGR) of 8.6%. The historical growth can be attributed to increasing occurrences of hemophilia and immunodeficiency disorders, an aging population, heightened demand for immunoglobulins, expansion of plasma collection centers, and a surge in surgical procedures.

In the coming years, the market size for plasma fractionation is predicted to experience swift expansion, with an expected worth projecting as high as $50.54 billion in 2029, demonstrating a compound annual growth rate (CAGR) of 10.3%. This anticipated growth over the forecast period can be tied to factors such as increased global healthcare spending, a surge in the usage of plasma-derived medications, greater investments in R&D, a heightened demand for plasma in addressing neurological conditions, and a wider dispersal of plasma fractionation facilities. The forecast period is also set to witness key trends, including the emergence of fresh fractionation technologies, a leaning towards albumin and immunoglobulin therapies, increased demand for specialty plasma products, a spotlight on pathogen inactivation technologies, along with strategic alliances and partnerships within the plasma industry.

Download The Free Sample Report Here:

https://www.thebusinessresearchcompany.com/sample.aspx?id=7543&type=smp

What factors are expected to fuel Plasma Fractionation market growth in the coming years?

The plasma fractionation market is anticipated to expand due to the rising prevalence of chronic diseases. These diseases, which include heart disease, cancer, and diabetes, are illnesses that persist for a duration of one year or more, necessitating sustained medical care. The utilization of plasma products to treat patients suffering from chronic ailments not only mitigates morbidity and enhances their quality of life but also offers cost-efficiency which in turn fuels plasma fractionation demand. For example, the National Library of Medicine, a US authority, released a report in January 2023 suggesting that the count of individuals over 50 having one or more chronic diseases is anticipated to surge by 99.5%, reaching 142.66 million by 2050 from 71.522 million in 2020. Consequently, the rising occurrence of chronic diseases is stimulating the healthcare analytical testing service market’s growth. Thus, the escalation in chronic diseases across all age groups is projected to drive the expansion of the plasma fractionation market.

What Are The Key Findings From The Segmentation Analysis Of The Plasma Fractionation Market?

The plasma fractionation market covered in this report is segmented –

1) By Product: Immunoglobulins, Coagulation Factors, Albumin, Protease Inhibitors

2) By Application: Immunology, Hematology, Neurology, Critical Care, Hemato-Oncology, Rheumatology

3) By End User: Hospitals and Clinics, Clinical Research Laboratories, Academic Institutes

Subsegments:

1) By Immunoglobulins: Intravenous Immunoglobulin (IVIG), Subcutaneous Immunoglobulin (SCIG)

2) By Coagulation Factors: Factor VIII, Factor IX, Prothrombin Complex Concentrates (PCC)

3) By Albumin: Human Albumin, Bovine Serum Albumin (BSA)

4) By Protease Inhibitors: Alpha-1 Antitrypsin (AAT), C1 Esterase Inhibitor (C1-INH)

Which Emerging Trends And Strategic Shifts Are Shaping The Plasma Fractionation Market?

Leading players in the market are adopting innovative technologies, for example, advanced facility processes that convert donated human plasma into crucial drugs, utilizing progressive technology to ensure the procedure is more safe and efficient. To exemplify, in March 2023, CSL Behring, a Germany-based company, inaugurated a new plasma fractionation facility with an investment of $470 million which employs state-of-the-art technology towards enhancing the efficiency and safety of plasma processing. This optimizes the quality and reliability of medical products. The increased supply of these essential drugs enabled by this facility caters to the escalating demand, guaranteeing broader patient access to vital treatment options. The facility also lowers contamination risks and improves hygiene standards due to its advanced automation and self-cleaning systems, thereby increasing patient safety.

What Are The Most Active Companies In The Plasma Fractionation Market Today?

Major companies operating in the plasma fractionation market include Baxter International Inc., Bio Products Laboratory Limited, Biotest AG, CSL Limited, Grifols S. A, ADMA Biologics Inc., Green Cross Corporation, Hualan Bioengineering Inc., Intas Pharmaceuticals Ltd., Japan Blood Products Organization, Kedrion S. P. A., Kamada Ltd., LFB Biomedicaments S. A. S, Octapharma AG, Sanquin Plasma Products B. V., Shanghai Raas Blood Products Co. Ltd., Takeda Pharmaceutical Company, Terumo BCT, China Biologic Products Holdings Inc., China National Biotec Group, Emergent BioSolutions Inc., Bharat Serum Vaccines Limited, Plasma Therapeutics, Prothya Biosolutions B. V., BioPharma Plasma LLC, BioLife Plasma Services LP

Get The Full Report Here:

https://www.thebusinessresearchcompany.com/report/plasma-fractionation-global-market-report

Which Regional Markets Are Attracting The Most Investment In Plasma Fractionation?

North America was the largest region in the plasma fractionation market in 2024.Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the plasma fractionation market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Request For A Customized Report:

https://www.thebusinessresearchcompany.com/customise?id=7543&type=smp

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

How Will the Plasma Fractionation Market Evolve in Terms of Growth and Size by 2029?

In recent times, the plasma fractionation market has experienced significant growth. The market size is projected to escalate from $31.42 billion in 2024 to $34.14 billion in 2025, presenting a compound annual growth rate (CAGR) of 8.6%. The historical growth can be attributed to increasing occurrences of hemophilia and immunodeficiency disorders, an aging population, heightened demand for immunoglobulins, expansion of plasma collection centers, and a surge in surgical procedures.

In the coming years, the market size for plasma fractionation is predicted to experience swift expansion, with an expected worth projecting as high as $50.54 billion in 2029, demonstrating a compound annual growth rate (CAGR) of 10.3%. This anticipated growth over the forecast period can be tied to factors such as increased global healthcare spending, a surge in the usage of plasma-derived medications, greater investments in R&D, a heightened demand for plasma in addressing neurological conditions, and a wider dispersal of plasma fractionation facilities. The forecast period is also set to witness key trends, including the emergence of fresh fractionation technologies, a leaning towards albumin and immunoglobulin therapies, increased demand for specialty plasma products, a spotlight on pathogen inactivation technologies, along with strategic alliances and partnerships within the plasma industry.

Download The Free Sample Report Here:

https://www.thebusinessresearchcompany.com/sample.aspx?id=7543&type=smp

What factors are expected to fuel Plasma Fractionation market growth in the coming years?

The plasma fractionation market is anticipated to expand due to the rising prevalence of chronic diseases. These diseases, which include heart disease, cancer, and diabetes, are illnesses that persist for a duration of one year or more, necessitating sustained medical care. The utilization of plasma products to treat patients suffering from chronic ailments not only mitigates morbidity and enhances their quality of life but also offers cost-efficiency which in turn fuels plasma fractionation demand. For example, the National Library of Medicine, a US authority, released a report in January 2023 suggesting that the count of individuals over 50 having one or more chronic diseases is anticipated to surge by 99.5%, reaching 142.66 million by 2050 from 71.522 million in 2020. Consequently, the rising occurrence of chronic diseases is stimulating the healthcare analytical testing service market’s growth. Thus, the escalation in chronic diseases across all age groups is projected to drive the expansion of the plasma fractionation market.

What Are The Key Findings From The Segmentation Analysis Of The Plasma Fractionation Market?

The plasma fractionation market covered in this report is segmented –

1) By Product: Immunoglobulins, Coagulation Factors, Albumin, Protease Inhibitors

2) By Application: Immunology, Hematology, Neurology, Critical Care, Hemato-Oncology, Rheumatology

3) By End User: Hospitals and Clinics, Clinical Research Laboratories, Academic Institutes

Subsegments:

1) By Immunoglobulins: Intravenous Immunoglobulin (IVIG), Subcutaneous Immunoglobulin (SCIG)

2) By Coagulation Factors: Factor VIII, Factor IX, Prothrombin Complex Concentrates (PCC)

3) By Albumin: Human Albumin, Bovine Serum Albumin (BSA)

4) By Protease Inhibitors: Alpha-1 Antitrypsin (AAT), C1 Esterase Inhibitor (C1-INH)

Which Emerging Trends And Strategic Shifts Are Shaping The Plasma Fractionation Market?

Leading players in the market are adopting innovative technologies, for example, advanced facility processes that convert donated human plasma into crucial drugs, utilizing progressive technology to ensure the procedure is more safe and efficient. To exemplify, in March 2023, CSL Behring, a Germany-based company, inaugurated a new plasma fractionation facility with an investment of $470 million which employs state-of-the-art technology towards enhancing the efficiency and safety of plasma processing. This optimizes the quality and reliability of medical products. The increased supply of these essential drugs enabled by this facility caters to the escalating demand, guaranteeing broader patient access to vital treatment options. The facility also lowers contamination risks and improves hygiene standards due to its advanced automation and self-cleaning systems, thereby increasing patient safety.

What Are The Most Active Companies In The Plasma Fractionation Market Today?

Major companies operating in the plasma fractionation market include Baxter International Inc., Bio Products Laboratory Limited, Biotest AG, CSL Limited, Grifols S. A, ADMA Biologics Inc., Green Cross Corporation, Hualan Bioengineering Inc., Intas Pharmaceuticals Ltd., Japan Blood Products Organization, Kedrion S. P. A., Kamada Ltd., LFB Biomedicaments S. A. S, Octapharma AG, Sanquin Plasma Products B. V., Shanghai Raas Blood Products Co. Ltd., Takeda Pharmaceutical Company, Terumo BCT, China Biologic Products Holdings Inc., China National Biotec Group, Emergent BioSolutions Inc., Bharat Serum Vaccines Limited, Plasma Therapeutics, Prothya Biosolutions B. V., BioPharma Plasma LLC, BioLife Plasma Services LP

Get The Full Report Here:

https://www.thebusinessresearchcompany.com/report/plasma-fractionation-global-market-report

Which Regional Markets Are Attracting The Most Investment In Plasma Fractionation?

North America was the largest region in the plasma fractionation market in 2024.Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the plasma fractionation market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Request For A Customized Report:

https://www.thebusinessresearchcompany.com/customise?id=7543&type=smp

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only._x000D_

_x000D_

#How Will the Plasma Fractionation Market Evolve in Terms of Growth and Size by 2029?#_x000D_

The substantial increase in the size of the plasma fractionation market has been evident in recent years. There is anticipated growth evident, from $31.42 billion in 2024 to $34.14 billion in 2025, with a compound annual growth rate (CAGR) of 8.6%. This growth during the former period can be ascribed to several factors, including an increased occurrence of hemophilia and immune deficiency disorders, a larger aging demographic, growing demand for immunoglobulins, expanding plasma collection centers, and an increase in surgical procedures._x000D_

_x000D_

Anticipations of robust growth are projected for the plasma fractionation market size in the forthcoming years, with estimates putting it at a worth of $50.54 billion in 2029 while registering a compound annual growth rate (CAGR) of 10.3%. Various factors like the increase in global healthcare spending, the expanding use of plasma-derived pharmaceutical products, the surge in investment in research & development, the rising use of plasma in neurology treatments, and the broadening of plasma fractionation facilities contribute to this predicted growth. The forecast period also anticipates significant trends such as the innovation of new fractionation techniques, a shift towards albumin and immunoglobulin therapies, heightened demand for specialized plasma products, an emphasis on pathogen inactivation technologies, along with strategic alliances and partnerships within the plasma industry._x000D_

_x000D_

#Download The Free Sample Report Here:#_x000D_

https://www.thebusinessresearchcompany.com/sample.aspx?id=7543&type=smp_x000D_

_x000D_

#What factors are expected to fuel Plasma Fractionation market growth in the coming years?#_x000D_

The anticipated growth of the plasma fractionation market is primarily fueled by the escalating prevalence of chronic diseases. These diseases, which require continuous medical intervention and last over a year, envelop conditions such as heart disease, cancer, and diabetes. By receiving access to plasma products, patients with these enduring illnesses can minimize their morbidity rate, enhance their quality of life and reduce treatment costs, naturally boosting the market demand for plasma fractionation. For example, a January 2023 report from the National Library of Medicine, an American institution, anticipates a 99.5% increase in the number of individuals aged 50 and over with one or more chronic diseases. This figure is projected to reach 142.66 million by 2050, contrasting with the 71.522 million recorded in 2020 within the United States. This surge in chronic disease cases is a significant driving force behind the expansion of the healthcare analytical testing service market. Thus, the growing number of chronic diseases across all age groups is projected to spur on the growth of the plasma fractionation market._x000D_

_x000D_

#What Are The Key Findings From The Segmentation Analysis Of The Plasma Fractionation Market?#_x000D_

The plasma fractionation market covered in this report is segmented – _x000D_

_x000D_

1) By Product: Immunoglobulins, Coagulation Factors, Albumin, Protease Inhibitors _x000D_

2) By Application: Immunology, Hematology, Neurology, Critical Care, Hemato-Oncology, Rheumatology_x000D_

3) By End User: Hospitals and Clinics, Clinical Research Laboratories, Academic Institutes_x000D_

_x000D_

Subsegments:_x000D_

1) By Immunoglobulins: Intravenous Immunoglobulin (IVIG), Subcutaneous Immunoglobulin (SCIG) _x000D_

2) By Coagulation Factors: Factor VIII, Factor IX, Prothrombin Complex Concentrates (PCC) _x000D_

3) By Albumin: Human Albumin, Bovine Serum Albumin (BSA) _x000D_

4) By Protease Inhibitors: Alpha-1 Antitrypsin (AAT), C1 Esterase Inhibitor (C1-INH) _x000D_

_x000D_

#Which Trends Are Expected To Shape The Future Of The Plasma Fractionation Market?#_x000D_

Leading companies in the market are embracing innovative technologies such as advanced facility processes which convert donated human plasma into essential medicines, enhancing both efficiency and safety. In March 2023, for example, German-based company CSL Behring launched a new plasma fractionation facility valued at $470 million, utilizing state-of-the-art technology to enhance the effectiveness and safety of plasma processing in order to guarantee higher-quality and more dependable medications. This facility aids in accommodating the increasing demand by supplementing the supply of these vital medicines, thereby expanding the number of patients who can benefit from life-saving therapies. The application of advanced automation and self-cleaning systems diminishes the chance of contamination, improves overall sanitary conditions, and boosts patient safety._x000D_

_x000D_

#What Are The Most Active Companies In The Plasma Fractionation Market Today?#_x000D_

Major companies operating in the plasma fractionation market include Baxter International Inc., Bio Products Laboratory Limited, Biotest AG, CSL Limited, Grifols S. A, ADMA Biologics Inc., Green Cross Corporation, Hualan Bioengineering Inc., Intas Pharmaceuticals Ltd., Japan Blood Products Organization, Kedrion S. P. A., Kamada Ltd., LFB Biomedicaments S. A. S, Octapharma AG, Sanquin Plasma Products B. V., Shanghai Raas Blood Products Co. Ltd., Takeda Pharmaceutical Company, Terumo BCT, China Biologic Products Holdings Inc., China National Biotec Group, Emergent BioSolutions Inc., Bharat Serum Vaccines Limited, Plasma Therapeutics, Prothya Biosolutions B. V., BioPharma Plasma LLC, BioLife Plasma Services LP _x000D_

_x000D_

#Get The Full Report Here:#_x000D_

https://www.thebusinessresearchcompany.com/report/plasma-fractionation-global-market-report_x000D_

_x000D_

#Which Regional Markets Are Attracting The Most Investment In Plasma Fractionation?#_x000D_

North America was the largest region in the plasma fractionation market in 2024.Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the plasma fractionation market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa_x000D_

_x000D_

#Request For A Customized Report:#_x000D_

https://www.thebusinessresearchcompany.com/customise?id=7543&type=smp_x000D_

_x000D_

#About The Business Research Company:#_x000D_

_x000D_

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game._x000D_

_x000D_

#Get in touch with us:#_x000D_

_x000D_

The Business Research Company: https://www.thebusinessresearchcompany.com/_x000D_

Americas +1 310-496-7795_x000D_

Asia +44 7882 955267 & +91 8897263534_x000D_

Europe +44 7882 955267_x000D_

Email us at info@tbrc.info_x000D_

_x000D_

#Follow us on:#_x000D_

_x000D_

LinkedIn: https://in.linkedin.com/company/the-business-research-company_x000D_

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ_x000D_

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

What Is the Growth Rate of the Plasma Fractionation Market?

The size of the plasma fractionation market has witnessed significant growth in the past years. It is projected to expand from $31.42 billion in 2024 to $34.44 billion in 2025, with a compound annual growth rate (CAGR) of 9.6%. Factors contributing to this growth during the historical period include an increase in hemophilia and immunodeficiency disorders, an aging population, the rise of demand for immunoglobulins, the expansion of plasma collection centers and an increase in the number of surgical procedures.

What Growth Rate Is Forecasted for the Plasma Fractionation Market by 2029?

In the next few years, the market size for plasma fractionation is projected to experience swift expansion, reaching $51.56 billion in 2029 with a compound annual growth rate (CAGR) of 10.6%. This growth during the forecast period is expected to be driven by factors such as an increase in worldwide health care spending, a growing use of plasma-derived medical products, a rise in research and development investment, a higher demand for plasma in treating neurological disorders, and the enlargement of plasma fractionation facilities. Other prominent trends for the forecast period include the emergence of new fractionation technologies, a shift towards albumin and immunoglobulin therapies, an increasing demand for specialty plasma products, an emphasis on pathogen inactivation technologies, and strategic alliances and partnerships within the plasma industry.

Download The Free Sample Report Here:

https://www.thebusinessresearchcompany.com/sample.aspx?id=7543&type=smp

Which Key Companies Are Shaping the Future of the Plasma Fractionation Market?

Major companies operating in the plasma fractionation market include Baxter International Inc., Bio Products Laboratory Limited, Biotest AG, CSL Limited, Grifols S. A, ADMA Biologics Inc., Green Cross Corporation, Hualan Bioengineering Inc., Intas Pharmaceuticals Ltd., Japan Blood Products Organization, Kedrion S. P. A., Kamada Ltd., LFB Biomedicaments S. A. S, Octapharma AG, Sanquin Plasma Products B. V., Shanghai Raas Blood Products Co. Ltd., Takeda Pharmaceutical Company, Terumo BCT, China Biologic Products Holdings Inc., China National Biotec Group, Emergent BioSolutions Inc., Bharat Serum Vaccines Limited, Plasma Therapeutics, Prothya Biosolutions B. V., BioPharma Plasma LLC, BioLife Plasma Services LP

Which Factors Are Driving Demand in the Plasma Fractionation Industry?

The proliferation of chronic diseases is likely to fuel the plasma fractionation market’s expansion. Chronic diseases such as heart disease, cancer, and diabetes, are conditions lasting over a year that necessitate continuous medical care. Utilizing plasma products to treat people with chronic conditions can reduce illness, enhance their quality of life, and offer cost-effectiveness, which will consequently escalate plasma fractionation demand. For instance, the National Library of Medicine, a U.S-based organization, reported in January 2023 that the population of individuals over 50 years old with one or more chronic diseases is predicted to surge by 99.5%, reaching 142.66 million by 2050, a significant jump from 71.522 million in 2020 in the United States. In short, the escalating prevalence of chronic diseases is contributing to the growth of the healthcare analytical testing service market. Therefore, the plasma fractionation market is likely to be driven by the rising number of chronic diseases across all age groups.

Request For A Customized Report:

https://www.thebusinessresearchcompany.com/customise?id=7543&type=smp

How Is the Plasma Fractionation Market Segmented by Several Divisions?

The plasma fractionation market covered in this report is segmented –

1) By Product: Immunoglobulins, Coagulation Factors, Albumin, Protease Inhibitors

2) By Application: Immunology, Hematology, Neurology, Critical Care, Hemato-Oncology, Rheumatology

3) By End User: Hospitals and Clinics, Clinical Research Laboratories, Academic Institutes

Subsegments:

1) By Immunoglobulins: Intravenous Immunoglobulin (IVIG), Subcutaneous Immunoglobulin (SCIG)

2) By Coagulation Factors: Factor VIII, Factor IX, Prothrombin Complex Concentrates (PCC)

3) By Albumin: Human Albumin, Bovine Serum Albumin (BSA)

4) By Protease Inhibitors: Alpha-1 Antitrypsin (AAT), C1 Esterase Inhibitor (C1-INH)

What are the Emerging Market Trends Driving the Growth of the Plasma Fractionation Industry?

Top corporations in the marketplace are unveiling novel technologies, such as hi-tech facility processes that convert donated human plasma into vital medicines, employing cutting-edge techniques to amplify efficiency and safety. For instance, in March 2023, a new $470 million plasma fractionation facility was opened by CSL Behring, a German-based firm. The establishment utilizes state-of-the-art technology to increase the effectiveness and safety of plasma processing, guaranteeing superior quality and more dependable medicines. By boosting the supply of these crucial medicines, the facility seeks to address the escalating demand, thereby ensuring more patients can access life-preserving therapies. The risk of contamination is reduced and overall hygiene conditions are improved thanks to advanced automation and self-cleaning systems, which ultimately enhances the safety of patients.

Access The Full Report Here:

https://www.thebusinessresearchcompany.com/report/plasma-fractionation-global-market-report

Which Regions Are Driving Growth in the Plasma Fractionation Market?

North America was the largest region in the plasma fractionation market in 2024.Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the plasma fractionation market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Purchase The Full Report Today:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=7543

This Report Delivers Insight On:

1. How big is the plasma fractionation market, and how is it changing globally?

2. Who are the major companies in the plasma fractionation market, and how are they performing?

3. What are the key opportunities and risks in the plasma fractionation market right now?

4. Which products or customer segments are growing the most in the plasma fractionation market?

5. What factors are helping or slowing down the growth of the plasma fractionation market?

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Discover trends, market shifts, and competitive outlooks for the plasma fractionation industry through 2025-2034 with The Business Research Company’s reliable data and in-depth research

#What is the Anticipated CAGR of the Plasma Fractionation Market, and What Factors Will Drive It?

Recent years have seen robust growth in the plasma fractionation market size. This market is expected to expand from $31.42 billion in 2024 to $34.44 billion in 2025, registering a compound annual growth rate (CAGR) of 9.6%. Factors contributing to this historical growth include an increased prevalence of hemophilia and immunodeficiency disorders, a rising aging population, an escalating demand for immunoglobulins, an expansion in the number of plasma collection centers, and an increase in surgical procedures.

In the upcoming years, the plasma fractionation market size is projected to experience a significant increase, with an expectation of reaching $51.56 billion in 2029 at a compound annual growth rate (CAGR) of 10.6%. The expected growth during this forecast period can be linked to increased global health care spending, more uses of plasma-derived medical products, enhanced attention to research and development, the need for plasma in addressing neurological conditions, and the expansion of plasma fractionation facilities. Key trends for the period under prediction include advancements in fractionation technologies, a shift to albumin and immunoglobulin treatments, heightened demand for specialty plasma products, an emphasis on pathogen inactivation technologies, and strategic alliances and partnerships in the plasma industry.

Download a free sample to assess the report’s scope and structure:

https://www.thebusinessresearchcompany.com/sample.aspx?id=7543&type=smp

What Are the Core Market Drivers Propelling Growth in the Plasma Fractionation Industry?

The growth of the plasma fractionation market is anticipated to be driven by the escalating incidence of chronic illnesses. Chronic diseases are defined as conditions that persist for a year or more and necessitate continual medical intervention. Examples include heart disease, cancer, and diabetes. Providing access to plasma products for chronic disease patients minimizes morbidity, enhances quality of life, and is cost-effective, resulting in a surge in plasma fractionation demand. For example, a report by the US-based National Library of Medicine published in January 2023 stated that the population aged 50 and above experiencing one or several chronic diseases is estimated to increase by 99.5%, reaching 142.66 million by 2050, up from 71.522 million in 2020 in the United States. Consequently, the healthcare analytical testing service market is being fueled by the rising prevalence of chronic diseases. Hence, the increase in chronic diseases across all age groups is predicted to fuel the growth of the plasma fractionation market.

How Is the Plasma Fractionation Market Segmented?

The plasma fractionation market covered in this report is segmented –

1) By Product: Immunoglobulins, Coagulation Factors, Albumin, Protease Inhibitors

2) By Application: Immunology, Hematology, Neurology, Critical Care, Hemato-Oncology, Rheumatology

3) By End User: Hospitals and Clinics, Clinical Research Laboratories, Academic Institutes

Subsegments:

1) By Immunoglobulins: Intravenous Immunoglobulin (IVIG), Subcutaneous Immunoglobulin (SCIG)

2) By Coagulation Factors: Factor VIII, Factor IX, Prothrombin Complex Concentrates (PCC)

3) By Albumin: Human Albumin, Bovine Serum Albumin (BSA)

4) By Protease Inhibitors: Alpha-1 Antitrypsin (AAT), C1 Esterase Inhibitor (C1-INH)

Request customized data on this market:

https://www.thebusinessresearchcompany.com/customise?id=7543&type=smp

Which Regions Are Driving the Next Phase of the Plasma Fractionation Market Growth?

North America was the largest region in the plasma fractionation market in 2024.Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the plasma fractionation market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

What Key Market Trends and Innovations Are Shaping the Future of the Plasma Fractionation Industry?

Leading corporations in the industry are implementing innovative technologies like high-tech facility processes that convert donated human plasma to essential medicines. These advancements augments the process’s efficiency and safety. For instance, in March 2023, German-based firm, CSL Behring inaugurated a new plasma fractionation facility, worth $470 million. This cutting-edge facility enhances the efficiency and safety of plasma processing, ensuring the production of superior quality and more dependable medicines. The new facility increases the availability of these vital medicines, thus addressing the rising demand and ensuring an increased number of patients have access to life-saving treatments. The incorporation of advanced automation and self-cleaning systems minimizes contamination risks and enriches the overall hygiene standards, thus improving patient safety.

View the full report here:

https://www.thebusinessresearchcompany.com/report/plasma-fractionation-global-market-report

How Is the Plasma Fractionation Market Defined and What Are Its Core Parameters?

Plasma fractionation refers to the process of integrating manufacturing procedures to isolate the crude fractions that are then refined into specific medicinal products, in a sequential and integrated manner.

Purchase the full report and get a swift delivery:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=7543

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

2025 Market Reports Update: Market Size Forecasts to 2034, Key Trends, Leading Players, and Top Regions – Get Ahead of the Competition Today!

What Industry-Specific Factors Are Fueling the Growth of thePlasma Fractionation Market?

The rise in chronic diseases is expected to contribute to the growth of the plasma fractionation market. Plasma products are essential for treating chronic diseases, which require ongoing medical attention. For instance, the National Library of Medicine reported that the number of people aged 50 years and older with chronic illnesses in the U.S. is expected to rise by 99.5% by 2050. This increasing prevalence of chronic diseases is expected to boost the demand for plasma fractionation.

Get Your Free Sample Report Now – Explore Exclusive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=7543&type=smp

#How Does the ProjectedPlasma Fractionation Market Growth Compare Over the Forecast Period?

The plasma fractionation market has experienced significant growth in recent years. It is projected to increase from $31.42 billion in 2024 to $34.44 billion in 2025, with a compound annual growth rate (CAGR) of 9.6%. This growth is mainly attributed to the rising prevalence of hemophilia and immunodeficiency disorders, an aging population, increasing demand for immunoglobulins, the expansion of plasma collection centers, and the growing number of surgical procedures.

The plasma fractionation market is projected to grow rapidly, reaching $51.56 billion by 2029 with a compound annual growth rate (CAGR) of 10.6%. This growth is driven by increasing global healthcare spending, expanding use of plasma-derived medicinal products, rising research and development investments, growing demand for plasma in treating neurological disorders, and the expansion of fractionation facilities. Key trends include new fractionation technologies, a shift toward albumin and immunoglobulin therapies, rising demand for specialty plasma products, focus on pathogen inactivation, and strategic collaborations in the plasma sector.

You can Directly Purchase the Report Here:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=7543

What Key Market Trends and Innovations Are Shaping the Future of thePlasma Fractionation Industry?

Companies in the plasma processing market are introducing new technologies to make the plasma fractionation process more efficient and safer. For example, in March 2023, CSL Behring, a German-based company, opened a $470 million plasma fractionation facility that uses advanced technology to improve efficiency and safety in plasma processing. This facility helps meet the increasing demand for high-quality medicines and ensures a safer, more hygienic process through automation and self-cleaning systems.

Which Companies Are Leading the Charge in Expanding thePlasma Fractionation Market Growth?

Major companies operating in the plasma fractionation market include Baxter International Inc., Bio Products Laboratory Limited, Biotest AG, CSL Limited, Grifols S. A, ADMA Biologics Inc., Green Cross Corporation, Hualan Bioengineering Inc., Intas Pharmaceuticals Ltd., Japan Blood Products Organization, Kedrion S. P. A., Kamada Ltd., LFB Biomedicaments S. A. S, Octapharma AG, Sanquin Plasma Products B. V., Shanghai Raas Blood Products Co. Ltd., Takeda Pharmaceutical Company, Terumo BCT, China Biologic Products Holdings Inc., China National Biotec Group, Emergent BioSolutions Inc., Bharat Serum Vaccines Limited, Plasma Therapeutics, Prothya Biosolutions B. V., BioPharma Plasma LLC, BioLife Plasma Services LP

Order Your Report Now For A Swift Delivery:

https://www.thebusinessresearchcompany.com/report/plasma-fractionation-global-market-report

How is the Global Plasma Fractionation Market Segemented?

The plasma fractionation market covered in this report is segmented –

1) By Product: Immunoglobulins, Coagulation Factors, Albumin, Protease Inhibitors

2) By Application: Immunology, Hematology, Neurology, Critical Care, Hemato-Oncology, Rheumatology

3) By End User: Hospitals and Clinics, Clinical Research Laboratories, Academic Institutes

Subsegments:

1) By Immunoglobulins: Intravenous Immunoglobulin (IVIG), Subcutaneous Immunoglobulin (SCIG)

2) By Coagulation Factors: Factor VIII, Factor IX, Prothrombin Complex Concentrates (PCC)

3) By Albumin: Human Albumin, Bovine Serum Albumin (BSA)

4) By Protease Inhibitors: Alpha-1 Antitrypsin (AAT), C1 Esterase Inhibitor (C1-INH)

Gain Exclusive Market Insights—Customize Your Research Report Today for Fast Delivery!

https://www.thebusinessresearchcompany.com/customise?id=7543&type=smp

Which Geographics are Influencing the Growth of the Plasma Fractionation Market?

North America was the largest region in the plasma fractionation market in 2024.Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the plasma fractionation market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Browse Through More Reports Similar to the Gobal Plasma Fractionation Maret 2025, By The Business Research Company:

Blood And Blood Components Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/blood-and-blood-components-global-market-report

Porcine Plasma Feed Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/porcine-plasma-feed-global-market-report

Blood Transfusion Diagnostics Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/blood-transfusion-diagnostics-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Contact us at:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on: